The Alzheimer's Foundation of America issued this statement today regarding passage of the National Alzheimer's Project Act. The National Alzheimer's Project Act would create the National Alzheimer's Project, which would coordinate government efforts to prevent and treat the disease and create a national strategy for defeating Alzheimer's disease. In September, the Alzheimer's Foundation of America had organized a sign on letter effort in support of H.R. 4689 and S. 3036, receiving the support of more than 100 organizations. Following the approval by the House of Representatives today and the Senate last week, the bill is now headed to President Obama for signature.
Statement by Eric J. Hall, president and CEO, Alzheimer's Foundation of America:
"We applaud the passage by the House of Representatives today and by the Senate last week of the National Alzheimer's Project Act, and especially thank Representatives Edward J. Markey (D-MA) and Representative Chris Smith (R-NJ) and Senators Evan Bayh (D-IN) and Susan Collins (R-ME) for championing the legislation.
"This momentous action marks an important recognition of the urgency of this public health crisis and the need for a strategic and coordinated approach that will lead to effective treatment and care. It is a victory both for families struggling with this disease each day and for organizations striving to make a difference.
"By setting in motion the first-ever national plan for tackling Alzheimer's disease, this act offers hope to the as many as 5.1 million Americans currently diagnosed with Alzheimer's disease, and their families, and those who face this brain disorder in the future. Its passage could not be timelier, as the first wave of baby boomers turn 65 in 2011 and confront increased risk of the disease.
"We hope that the passage of the National Alzheimer's Project Act marks a turning point in our nation's attention to and funding for this disease. The challenges that lie ahead are enormous and only by coming together can we make progress toward care and cure."
Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy